Brief: Akoya Provides Full Year 2024 Financial Outlook
04/03/2024 21:11
March 4 (Reuters) - Akoya Biosciences Inc AKYA.O :
* AKOYA REPORTS RECORD REVENUE IN THE FOURTH QUARTER OF 2023
AND
PROVIDES FULL YEAR 2024 FINANCIAL OUTLOOK
* AKOYA BIOSCIENCES INC - Q4 2023 REVENUE $26.5 MILLION
* AKOYA BIOSCIENCES INC - GUIDING FY 2024 REVENUE RANGE
$114.0-118.0 MILLION AND OPERATING CASH FLOW BREAKEVEN BY YE
2024
* AKOYA BIOSCIENCES INC - $83.1 MILLION OF CASH AND CASH
EQUIVALENTS AS OF DECEMBER 31, 2023
Source text for Eikon: ID:nGNX9QxRDB
Further company coverage: AKYA.O
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks